+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Inhalers Market - Global Forecast to 2030- Product Image
Respiratory Inhalers Market - Global Forecast to 2030- Product Image
Sale

Respiratory Inhalers Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012372
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Respiratory Inhalers Market grew from USD 3.24 billion in 2024 to USD 3.56 billion in 2025. It is expected to continue growing at a CAGR of 9.84%, reaching USD 5.69 billion by 2030.

In recent years, the respiratory inhalers market has witnessed significant evolution driven by rising prevalence of respiratory diseases, rapid technological advancements, and shifting regulatory landscapes. Asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pulmonary arterial hypertension continue to impose a growing global health burden, compelling manufacturers and healthcare providers to innovate delivery mechanisms that enhance efficacy, patient adherence, and ease of use. Concurrently, environmental concerns over propellant types and increased demand for digital health integration have prompted industry stakeholders to pursue greener and smarter inhalation platforms. This report provides an executive summary of key trends, challenges, and opportunities shaping the respiratory inhalers sector, offering decision-makers a concise yet comprehensive view of market dynamics. As stakeholders seek to optimize treatment outcomes and capture emerging growth pockets, understanding the interplay between product innovation, disease epidemiology, distribution channels, and regulatory shifts becomes critical. Transitioning from this foundational overview, the next section delves into transformative shifts redefining competitive strategies and patient-centric solutions across the inhalers landscape.

Key Transformative Shifts Shaping the Market

Building on an understanding of market fundamentals, several transformative shifts are redefining how respiratory inhalers are developed, marketed, and adopted. First, integration of digital health technologies has accelerated, with connected inhalers offering real-time usage tracking and adherence monitoring that empower patients and inform clinicians. Second, environmental sustainability has become a strategic imperative: the phase-out of chlorofluorocarbon propellants and adoption of hydrofluoroalkane alternatives, along with the development of propellant-free devices, reflect both regulatory pressures and corporate commitments to reduce carbon footprints. Third, regulatory frameworks worldwide are evolving to expedite approvals for combination therapies and smart inhaler systems, incentivizing partnerships between pharmaceutical companies and technology providers. Fourth, patient demographics and preferences are shifting: pediatric and geriatric populations demand user-friendly designs, while adult patients increasingly prioritize convenience and portability. Finally, strategic collaborations and mergers are reshaping competitive dynamics, as global and regional players leverage complementary capabilities to broaden product portfolios and strengthen supply chains. Together, these shifts are accelerating innovation, intensifying competition, and unlocking new avenues for differentiation.

Assessing the Impact of United States Tariffs in 2025

The implementation of United States tariffs on components and raw materials in 2025 is poised to exert a multifaceted influence on the respiratory inhalers market. As import duties apply to specialized polymers, actuator mechanisms, and high-precision sensors used in smart inhalers, manufacturers face heightened production costs that may translate into pricing adjustments or margin compression. In response, several companies are exploring nearshoring or local assembly operations to mitigate tariff exposure and streamline supply chains. At the same time, distributors and healthcare providers are recalibrating procurement strategies, balancing cost containment with the need to maintain uninterrupted access to critical therapies. Tariffs on key propellant imports could also accelerate the transition toward hydrofluoroalkanes and propellant-free technologies, as domestic sourcing becomes more attractive. From a regional perspective, smaller contract manufacturing organizations may experience competitive pressure if unable to absorb higher input costs, while larger integrators with diversified sourcing networks stand to gain market share. These dynamics underscore the importance of proactive scenario planning, strategic partnerships, and continuous monitoring of trade policies to safeguard profitability and ensure strategic resilience in an increasingly protectionist environment.

Comprehensive Segmentation Insights Across Market Dimensions

An in-depth analysis across multiple segmentation dimensions reveals nuanced market behaviors and growth opportunities. Based on product type, Dry Powder Inhalers, including multi-dose and single-dose variants, continue to capture significant share due to ease of storage and environmental advantages; Metered Dose Inhalers, encompassing breath-actuated and pressurized designs, remain prevalent for rapid drug delivery; Nebulizers, such as jet, mesh, and ultrasonic devices, are favored in acute care and pediatric settings; and Soft Mist Inhalers offer high pulmonary deposition with minimal coordination effort. In the realm of disease type, adult and pediatric asthma segments benefit from tailored dosing regimens, while chronic bronchitis and emphysema subgroups within COPD demand combination therapies that address both inflammatory and bronchoconstrictive components; cystic fibrosis and pulmonary arterial hypertension, though niche, require specialized formulations and delivery mechanisms. Distribution channel analysis indicates that hospital pharmacies manage bulk procurement for inpatient care, retail pharmacies serve walk-in patients seeking maintenance therapies, and online pharmacies provide convenience and discreet replenishment options. Examining technology, conventional inhalers retain broad acceptance but smart inhalers with Bluetooth-enabled tracking and embedded sensors are rapidly gaining traction for remote monitoring and personalized interventions. End users range from clinics and hospitals delivering acute treatments to homecare settings where patient education and adherence play critical roles. Within drug class segmentation, corticosteroids and leukotriene modifiers within anti-inflammatory categories, anticholinergics and beta-agonists under bronchodilators, and combination drugs that integrate both mechanisms shape formulary preferences. Propellant type trends underscore the industry shift from chlorofluorocarbon to hydrofluoroalkane options, while prescription and over-the-counter classifications influence patient access models.

Critical Regional Dynamics Influencing Growth

Regional dynamics in the respiratory inhalers sector reflect disparate healthcare infrastructures, regulatory environments, and patient demographics. In the Americas, strong reimbursement policies and established distribution networks in the United States and Canada support widespread adoption of advanced inhaler technologies, whereas Latin American markets prioritize cost-effective solutions and local manufacturing partnerships. Europe, Middle East & Africa exhibit a heterogeneous landscape: Western Europe leads in smart inhaler deployment and environmental compliance initiatives, while Eastern European markets display growing demand for generics and biosimilars; Middle Eastern investment in healthcare modernization drives adoption of portable nebulizers; and select African nations focus on building primary care capacities to address rising asthma and COPD prevalence. In the Asia-Pacific region, rapid urbanization and improved diagnostic infrastructure in markets like China, Japan, and Australia boost demand for both conventional and smart inhalers, while Southeast Asian and South Asian markets reveal untapped potential in homecare settings and online pharmacy channels. Across these regions, regulatory harmonization efforts, local vs. global manufacturer strategies, and digital health policies will be key determinants of future growth trajectories.

Leading Players and Competitive Dynamics Overview

Competitive intensity within the respiratory inhalers market is driven by a mix of global pharmaceutical giants, specialized device manufacturers, and emerging technology providers. AstraZeneca PLC and GlaxoSmithKline PLC leverage expansive R&D pipelines and extensive distribution channels to lead in combination therapies and smart inhaler platforms. Novartis AG and Merck & Co., Inc. maintain strong portfolios in both bronchodilators and anti-inflammatory drug classes, enabling cross-segment synergies and robust patient loyalty programs. Cipla Limited, Lupin Limited, and Cadila Healthcare Ltd. capitalize on cost-leadership in generics, particularly in price-sensitive regions. Chiesi Farmaceutici S.p.A. and C.H. Boehringer Sohn Ko. KG drive innovation in propellant-free and silicone-based device technologies, while Koninklijke Philips N.V. and Microlife Corporation expand digital health offerings through sensor integration and remote monitoring solutions. Beximco Pharmaceuticals Ltd. and Opko Health, Inc. focus on niche markets such as pulmonary arterial hypertension and pediatric asthma, partnering with contract manufacturing organizations like Heltman Medikal A.S. to scale production. Teva Pharmaceutical Industries Ltd. and Rossmax International Ltd. strengthen market presence through strategic acquisitions and licensing agreements, underscoring the ongoing consolidation trend. Together, these leaders shape market direction through differentiated product portfolios, cross-industry collaborations, and targeted geographic expansion.

Actionable Recommendations for Industry Stakeholders

To capitalize on evolving market dynamics, industry stakeholders should consider a multi-pronged strategic approach. First, investment in smart inhaler technologies and digital adherence platforms will differentiate offerings and foster long-term patient engagement. Second, diversifying manufacturing footprints and establishing regional assembly hubs can mitigate tariff risks and optimize supply chain resilience. Third, forging alliances with technology providers and academic research centers will accelerate development of next-generation devices and novel formulations. Fourth, customizing product portfolios to address regional healthcare policies and demographic needs-such as pediatric-friendly designs in emerging markets or environmentally compliant propellants in Europe-will enhance market penetration. Fifth, leveraging omnichannel distribution strategies that integrate hospital procurement, retail partnerships, and e-commerce platforms will streamline patient access and improve refill rates. Finally, implementing robust pharmacovigilance and real-world evidence programs will strengthen regulatory positioning and inform iterative product improvements.

Concluding Perspectives on Future Market Trajectories

The respiratory inhalers market stands at a pivotal juncture where technological innovation, environmental responsibility, and regulatory evolution converge to redefine value creation. Stakeholders who effectively harness insights from digital health integration, segmentation nuances, and regional dynamics will be well-positioned to outpace competitors and deliver superior patient outcomes. Navigating the implications of evolving tariff landscapes, maintaining agile supply chains, and cultivating strategic partnerships will be critical to sustaining growth and profitability. As patient expectations continue to evolve, success will depend on blending scientific rigor with user-centric design and data-driven engagement strategies. Ultimately, the most resilient players will be those that balance innovation with operational excellence and demonstrate unwavering commitment to improving respiratory health on a global scale.

Market Segmentation & Coverage

This research report categorizes the Respiratory Inhalers Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Dry Powder Inhalers (DPI)
    • Multi-dose DPI
    • Single-dose DPI
  • Metered Dose Inhalers (MDI)
    • Breath-Actuated MDI
    • Pressurized MDI
  • Nebulizers
    • Jet Nebulizers
    • Mesh Nebulizers
    • Ultrasonic Nebulizers
  • Soft Mist Inhalers (SMI)
  • Asthma
    • Adult Asthma
    • Pediatric Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
    • Chronic Bronchitis
    • Emphysema
  • Cystic Fibrosis
  • Pulmonary Arterial Hypertension (PAH)
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Conventional Inhalers
  • Smart Inhalers
    • Bluetooth-Enabled Inhalers
    • Sensors Fitted Inhalers
  • Clinics
  • Homecare Settings
  • Hospitals
  • Anti-Inflammatory Drugs
    • Corticosteroids
    • Leukotriene Modifiers
  • Bronchodilators
    • Anticholinergics
    • Beta-Agonists
  • Combination Drugs
  • Chlorofluorocarbons (CFCs)
  • Hydrofluoroalkanes (HFAs)
  • Over-The-Counter Inhalers
  • Prescription Inhalers

This research report categorizes the Respiratory Inhalers Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Respiratory Inhalers Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AstraZeneca PLC
  • Beximco Pharmaceuticals Ltd.
  • C.H. Boehringer Sohn Ko. KG
  • Cadila Healthcare Ltd.
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • GlaxoSmithKline PLC
  • Heltman Medikal A.S.
  • Koninklijke Philips N.V.
  • Lupin Limited
  • Merck & Co., Inc.
  • Microlife Corporation
  • Novartis AG
  • Opko Health, Inc.
  • Rossmax International Ltd.
  • Teva Pharmaceutical Industries Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Respiratory Inhalers Market, by Product Type
8.1. Introduction
8.2. Dry Powder Inhalers (DPI)
8.2.1. Multi-dose DPI
8.2.2. Single-dose DPI
8.3. Metered Dose Inhalers (MDI)
8.3.1. Breath-Actuated MDI
8.3.2. Pressurized MDI
8.4. Nebulizers
8.4.1. Jet Nebulizers
8.4.2. Mesh Nebulizers
8.4.3. Ultrasonic Nebulizers
8.5. Soft Mist Inhalers (SMI)
9. Respiratory Inhalers Market, by Disease Type
9.1. Introduction
9.2. Asthma
9.2.1. Adult Asthma
9.2.2. Pediatric Asthma
9.3. Chronic Obstructive Pulmonary Disease (COPD)
9.3.1. Chronic Bronchitis
9.3.2. Emphysema
9.4. Cystic Fibrosis
9.5. Pulmonary Arterial Hypertension (PAH)
10. Respiratory Inhalers Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Respiratory Inhalers Market, by Technology
11.1. Introduction
11.2. Conventional Inhalers
11.3. Smart Inhalers
11.3.1. Bluetooth-Enabled Inhalers
11.3.2. Sensors Fitted Inhalers
12. Respiratory Inhalers Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Homecare Settings
12.4. Hospitals
13. Respiratory Inhalers Market, by Drug Class
13.1. Introduction
13.2. Anti-Inflammatory Drugs
13.2.1. Corticosteroids
13.2.2. Leukotriene Modifiers
13.3. Bronchodilators
13.3.1. Anticholinergics
13.3.2. Beta-Agonists
13.4. Combination Drugs
14. Respiratory Inhalers Market, by Propellant Type
14.1. Introduction
14.2. Chlorofluorocarbons (CFCs)
14.3. Hydrofluoroalkanes (HFAs)
15. Respiratory Inhalers Market, by Prescription Type
15.1. Introduction
15.2. Over-The-Counter Inhalers
15.3. Prescription Inhalers
16. Americas Respiratory Inhalers Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Respiratory Inhalers Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Respiratory Inhalers Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. AstraZeneca PLC
19.3.2. Beximco Pharmaceuticals Ltd.
19.3.3. C.H. Boehringer Sohn Ko. KG
19.3.4. Cadila Healthcare Ltd.
19.3.5. Chiesi Farmaceutici S.p.A.
19.3.6. Cipla Limited
19.3.7. GlaxoSmithKline PLC
19.3.8. Heltman Medikal A.S.
19.3.9. Koninklijke Philips N.V.
19.3.10. Lupin Limited
19.3.11. Merck & Co., Inc.
19.3.12. Microlife Corporation
19.3.13. Novartis AG
19.3.14. Opko Health, Inc.
19.3.15. Rossmax International Ltd.
19.3.16. Teva Pharmaceutical Industries Ltd.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. RESPIRATORY INHALERS MARKET MULTI-CURRENCY
FIGURE 2. RESPIRATORY INHALERS MARKET MULTI-LANGUAGE
FIGURE 3. RESPIRATORY INHALERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RESPIRATORY INHALERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MULTI-DOSE DPI, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SINGLE-DOSE DPI, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY BREATH-ACTUATED MDI, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRESSURIZED MDI, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS (SMI), BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULT ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY EMPHYSEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION (PAH), BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CONVENTIONAL INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY BLUETOOTH-ENABLED INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SENSORS FITTED INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY LEUKOTRIENE MODIFIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY BETA-AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHLOROFLUOROCARBONS (CFCS), BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY HYDROFLUOROALKANES (HFAS), BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY OVER-THE-COUNTER INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 64. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 65. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 69. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 97. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 98. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 102. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 111. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 113. CANADA RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 114. CANADA RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 115. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. CANADA RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 117. CANADA RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 118. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. CANADA RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. CANADA RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 121. CANADA RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 123. CANADA RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 124. CANADA RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 125. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 126. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 129. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 130. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 133. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 134. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 193. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 195. CHINA RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 196. CHINA RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 197. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 198. CHINA RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 199. CHINA RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 200. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. CHINA RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. CHINA RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 203. CHINA RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 205. CHINA RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 206. CHINA RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 207. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 208. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 209. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 211. INDIA RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 212. INDIA RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 213. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 214. INDIA RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 215. INDIA RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 216. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. INDIA RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. INDIA RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 219. INDIA RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 221. INDIA RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 222. INDIA RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 223. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 224. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 227. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 228. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 232. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 241. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 243. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 244. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 245. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 246. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 247. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 248. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 251. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 253. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 254. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 255. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 256. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 280. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 292. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 293. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 294. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 295. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 296. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 299. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 301. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY SMART INHALERS, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PROPELLANT TYPE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALERS (DPI), 2018-2030 (USD MILLION)
TABLE 323. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALERS (MDI), 2018-2030 (USD MILLION)
TABLE 324. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 327. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY CHRON

Companies Mentioned

  • AstraZeneca PLC
  • Beximco Pharmaceuticals Ltd.
  • C.H. Boehringer Sohn Ko. KG
  • Cadila Healthcare Ltd.
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • GlaxoSmithKline PLC
  • Heltman Medikal A.S.
  • Koninklijke Philips N.V.
  • Lupin Limited
  • Merck & Co., Inc.
  • Microlife Corporation
  • Novartis AG
  • Opko Health, Inc.
  • Rossmax International Ltd.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Digital Dose Inhaler Market - Global Forecast to 2030 - Product Image

Digital Dose Inhaler Market - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Inhalers & Nebulizers Market by Product, Indication, Distribution Mode - Global Forecast 2025-2030 - Product Image

Inhalers & Nebulizers Market by Product, Indication, Distribution Mode - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Respiratory Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Respiratory Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From
Smart Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Smart Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.